Specific recognition of t(6;9)-positive leukemia cells by DEK-CAN fusion peptide-specific CD4+ T lymphocytes in an HLA-DR-restricted manner.

被引：0
|
作者：
Makita, M
Azuma, T
Hamaguchi, H
Fujita, S
Tanimoto, M
Harada, M
Yasukawa, M
机构：
[1] Ehime Univ, Sch Med, Dept Internal Med 1, Shigenobu, Ehime 79102, Japan
[2] Musashino Red Cross Hosp, Dept Hematol, Musashino, Tokyo, Japan
[3] Okayama Univ, Grad Sch Med, Dept Biopathol Sci, Okayama, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosystem Sci, Fukuoka, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：121A / 121A
页数：1
相关论文
共 50 条
  • [31] THE INVOLVEMENT OF T-CELL RECEPTOR PEPTIDE-SPECIFIC REGULATORY CD4+ T-CELLS IN RECOVERY FROM ANTIGEN-INDUCED AUTOIMMUNE-DISEASE
    KUMAR, V
    SERCARZ, EE
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03): : 909 - 916
  • [32] Cutting edge:: Detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state
    Cameron, TO
    Cochran, JR
    Yassine-Diab, B
    Sékaly, RP
    Stern, LJ
    JOURNAL OF IMMUNOLOGY, 2001, 166 (02): : 741 - 745
  • [33] In vitro peptide immunization of target Tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes
    Kobayashi, Hiroya
    Ngato, Toshihiro
    Sato, Keisuke
    Aoki, Naoko
    Kimura, Shoji
    Tanaka, Yuetsu
    Aizawa, Hitoshi
    Tateno, Masatoshi
    Celis, Esteban
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3814 - 3822
  • [34] MURINE ENTEROCYTES CAN PRESENT SOLUBLE-ANTIGEN TO SPECIFIC CLASS-II-RESTRICTED CD4+ T-CELLS
    KAISERLIAN, D
    VIDAL, K
    REVILLARD, JP
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) : 1513 - 1516
  • [35] Establishment of HLA-DR-restricted BCR-ABL (b2a2 and b3a2) fusion protein-specific CD4(+) cytotoxic T-cell clones
    Yasukawa, M
    Ohminami, H
    Kaneko, S
    Yakushijin, Y
    Fujita, S
    BLOOD, 1997, 90 (10) : 877 - 877
  • [36] Circulating Preproinsulin Signal Peptide-Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-Cells
    Kronenberg, Deborah
    Knight, Robin R.
    Estorninho, Megan
    Ellis, Richard J.
    Kester, Michel G.
    de Ru, Arnoud
    Eichmann, Martin
    Huang, Guo C.
    Powrie, Jake
    Dayan, Colin M.
    Skowera, Ania
    van Veelen, Peter A.
    Peakman, Mark
    DIABETES, 2012, 61 (07) : 1752 - 1759
  • [37] CD4+ CD25+ regulatory T cells control the upper limit of peptide-specific CD8+ T-cell expansion following secondary L-monocytogenes infection
    Montfort, MJ
    Bouwer, HGA
    Wagner, CR
    Hinrichs, DJ
    FASEB JOURNAL, 2005, 19 (04): : A395 - A396
  • [38] ACTIVATION OF HLA-RESTRICTED EBV-SPECIFIC CYTO-TOXIC T-CELLS DOES NOT REQUIRE CD4+ (HELPER) T-CELLS OR EXOGENOUS CYTOKINES
    FISHWILD, DM
    BENIKE, CJ
    ENGLEMAN, EG
    JOURNAL OF IMMUNOLOGY, 1988, 140 (06): : 1994 - 1998
  • [39] HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4+ T lymphocytes
    Yasukawa, M
    Ohminami, H
    Kojima, K
    Hato, T
    Hasegawa, A
    Takahashi, T
    Hirai, H
    Fujita, S
    BLOOD, 2001, 98 (05) : 1498 - 1505
  • [40] MODULATION OF EAE BY VACCINATION WITH T-CELL RECEPTOR PEPTIDES - V-BETA-8 T-CELL RECEPTOR PEPTIDE-SPECIFIC CD4+ LYMPHOCYTES LACK DIRECT IMMUNOREGULATORY ACTIVITY
    JUNG, S
    SCHLUESENER, HJ
    TOYKA, KV
    HARTUNG, HP
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 45 (1-2) : 15 - 22
12345